Carsten Bokemeyer

39PUBLICATIONS
222CO-AUTHORS
Molecular targetsHaematological tumoursMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Sep 19, 2025
Clinical Benefit From Molecularly Guided Cancer Care: A Matching-Adjusted Indirect Comparison of Larotrectinib Versus Standard of Care.

Carsten Bokemeyer, Keith R Abrams, Jesus Garcia-Foncillas

|Jun 26, 2025
Downregulation of S6 Kinase and Hedgehog-Gli1 by Inhibition of Fatty Acid Synthase in AML with FLT3-ITD Mutation.

Maxim Kebenko, Ruimeng Zhuang, Konstantin Hoffer

|Jun 17, 2025
Streamlining and Accelerating the Molecular Tumor Board Process at the University Medical Center Hamburg-Eppendorf.

Layla Tabea Riemann, Maximilian Ataian, Felicia P S Hähner

|Apr 29, 2025
6-[(1,4-Naphthoquinone-2-yl)methyl]thio-Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer.

Tobias Busenbender, Dmitry N Pelageev, Jessica Hauschild

|Mar 28, 2025
Functional Role of Fatty Acid Synthase for Signal Transduction in Core-Binding Factor Acute Myeloid Leukemia with an Activating c-Kit Mutation.

Ruimeng Zhuang, Bente Siebels, Konstantin Hoffer

|Nov 11, 2024
Inflammatory Stress Determines the Need for Chemotherapy in Patients with HER2-Positive Esophagogastric Adenocarcinoma Receiving Targeted Therapy and Immunotherapy.

Joseph Tintelnot, Lisa Paschold, Eray Goekkurt

Pageof 7

Frequent Collaborators

7 joint publications

Walter Fiedler

7 joint publications

Sergey A Dyshlovoy

4 joint publications

Richard Adams

4 joint publications

Volker Heinemann